TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways.
Chan W, Cao YM, Zhao X, Schrom EC, Jia D, Song J, Sibener LV, Dong S, Fernandes RA, Bradfield CJ, Smelkinson M, Kabat J, Hor JL, Altan-Bonnet G, Garcia KC, Germain RN.
Chan W, et al. Among authors: bradfield cj.
J Exp Med. 2023 Dec 4;220(12):e20231242. doi: 10.1084/jem.20231242. Epub 2023 Oct 5.
J Exp Med. 2023.
PMID: 37796477
Free PMC article.